EI 11 Equity Analyst Research Reports
An equity research report is written to persuade. Its purpose is not to file a neutral summary of recent events, and it is not a regulatory disclosure, which is the company’s responsibility. The purpose is to deliver a recommendation that is backed by analysis, so that a reader can follow it and act. Because the report must convince, it has to give the reader a solid grasp of the company, its industry, and its competitive setting before the argument for the recommendation lands.
The recommendation itself is a short verdict on expected share price performance. Analysts commonly express it as buy, sell, or hold. Some use the portfolio-weighting language of overweight, underweight, or neutral to say the same thing on a relative basis. The verdict can be framed in absolute terms, meaning the expected total return on the stock itself, or on a relative basis, measured against an index, a benchmark for the relevant industry or region, or the pool of names a given analyst follows.
The price target and the time horizon
Behind every recommendation sits a price target: the expected future share price that follows from the analyst’s valuation. Comparing that target with the current price gives an expected return, measured over a stated horizon that is usually one or two years. The horizon can shift around company milestones such as a research trial result, a regulatory approval, or a patent expiry.
No single industry standard defines the cut-offs, but a common rule of thumb runs as follows. A stock rated buy is expected to rise at least 10 to 15 percent on an absolute basis, or to beat its benchmark by that margin. A sell rating implies a decline, or a shortfall against the benchmark, of at least 10 to 15 percent. A hold or neutral rating sits between the two. Because relative ratings compare a stock against its peers, a share expected to earn a modest positive absolute return can still be rated sell or underweight if its peers are expected to do markedly better.
Context shapes the report
A report that initiates coverage presents a company to an audience seeing it for the very first time, frequently just after an IPO, with a full discussion of the industry, competitive position, and outlook. An ongoing or periodic report is shorter and reacts to a specific event, such as a merger, an acquisition, or a scheduled earnings release. In every case the analyst weighs both transitory factors and longer-term forces, then distils them into one recommendation, as the next example shows.
InterGlobe Aviation Ltd. runs IndiGo, the largest passenger airline in India. In the fiscal year ended March 2024 the company generated INR674 billion in revenue and INR82 billion in net income. In early 2025, following a quarterly results release, a sell-side firm issued an overweight recommendation with expected price appreciation of almost 20 percent over the next year. Quarterly earnings per share landed 16 percent under expectations, yet the analyst lifted the price target by 3 percent.
A junior analyst covering European beverages compiles current and target prices for four peers over a one-year horizon. The relevant equity benchmark is expected to rise 12 percent over the same twelve months.
| Company | Current price | Target price (1 year) |
|---|---|---|
| Carlsberg AS | DKK910 | DKK930 |
| Anheuser-Busch InBev SA/NV | EUR62 | EUR77 |
| Diageo PLC | GBP1,840 | GBP1,900 |
| Pernod Ricard SA | EUR88 | EUR83 |
Although the emphasis varies with the analyst’s perspective, most reports share a common skeleton: an opening summary and thesis, a description of the business and its competitive setting, financial analysis and valuation, a discussion of risks, and often a section on sustainability. The qualitative parts build the reader’s understanding; the quantitative parts turn that understanding into a valuation and a target price.
The opening summary and thesis
A strong report leads with the recommendation, stated plainly. The price target can be a single point estimate or a range. Following that headline, the analyst condenses the reasoning into an investment thesis: a short, focused statement of why the stock is mispriced and what will close the gap. The thesis usually names company-specific drivers alongside the economic and industry conditions that support the predicted outcome, and it is tied directly to reaching the target within the stated horizon. Catalysts, meaning specific events or developments expected to move the market price toward intrinsic value, are listed because the thesis often depends on them.
The first page usually carries basic reference data: the ticker, the main sector and industry, market capitalization and float, notable recent events, and a snapshot of recent and projected financials, with earnings featured most prominently. Although this material sits at the front, it is written last so that it stays consistent with everything that follows.
BioAge Labs Inc. (BIOA) is an early-stage US biotechnology company that went public late in 2024. Shortly after the IPO, in December 2024, it halted the clinical trial of its obesity drug. Before that news, the consensus analyst expectation had the stock rising well above USD40 per share.
Business description and competitive positioning
An initiation report should describe the firm and its business model in detail: products, services, major suppliers and customers, and above all how the company creates value, including the key drivers of revenue and expense. The management discussion and analysis in the annual report, other regulatory filings, industry publications, and press releases are the natural starting points. Even when the analyst brings specialist knowledge, for instance in biotechnology or semiconductors, the description should be pitched to a broad investor audience rather than to fellow specialists. Pricing, distribution, and the stability of market share are also worth addressing here.
Because a firm’s competitors are the nearest substitutes for owning its shares, a good report surveys the competitive environment and the industry the firm operates in. Analysts should assemble a peer group for comparison. Some firms name competitors in their filings, and in the United States proxy statements often identify peers explicitly, though those lists may reach beyond direct rivals. A thorough industry analysis usually draws, explicitly or not, on Porter’s Five Forces and on the political, economic, social, technological, legal, and environmental (PESTLE) framework. The aim is not to tick off every force and every PESTLE element mechanically, but to concentrate on the factors with the greatest impact on performance.
Birkenstock Holding PLC (BIRK) went public in October 2023. Despite being a well-known global shoe brand, Birkenstock does not name specific competitors in its investor filings, so an analyst must build a peer group from other sources. Bloomberg’s relative value tools most often flag ON Holding AG (ONON) as comparable, while FactSet most often cites Crocs Inc. (CROX); other searches surface Skechers USA Inc. (SKX) and Dr. Martens PLC (DOCS).
Financial analysis
The strongest reports pair the qualitative picture with quantitative work that supports a credible valuation. The financial analysis should not attempt an exhaustive review of the statements; it should highlight the key measures and ratios that reflect the analyst’s economic reading of the company and reinforce the thesis and valuation. Analysts are advised to read the firm’s disclosures and footnotes directly rather than lean on data vendors, because the detail helps flag risks such as poor earnings quality or aggressive revenue or expense recognition. Industry-specific ratios often appear here, for example proven reserves for oil companies, revenue per available room for hotels, or capacity metrics for airlines.
An InterGlobe Aviation report uses airline-specific metrics built around available seat kilometers (ASK), which multiply the seats offered across all flights by the kilometers flown. Framing revenue and cost per ASK gives readers the unit economics that can be compared across airlines. Management reported 22 percent ASK growth as traffic recovered from the pandemic. The analyst forecasts continued double-digit ASK growth, a slight decline in revenue per ASK (RASK) versus fiscal 2024, and meaningful improvement in non-fuel cost per ASK (CASK).
Valuation
A full analysis of the financial statements feeds the valuation used to justify the recommendation. Analysts typically apply more than one approach and may mix absolute models, such as discounted cash flow, with relative models based on multiples. The detail of a cash flow projection depends on the firm’s own value drivers. Using multiples requires selecting the right ratios and defining them consistently across the firm and a carefully chosen peer group.
Soon after the October 2023 IPO, an initiation report set a hold rating on Birkenstock with a target roughly 5 percent above the recent price, based on a discounted cash flow valuation. The narrative rested on the company’s dominant niche position: sandals made in Europe rather than outsourced to Asia, loyal customers, and low marketing spend. Those themes fed strong forecast revenue growth and double-digit expansion of earnings before interest and taxes across the first ten forecast years. Because Birkenstock is listed in the United States but operates in Europe, the target was benchmarked against ten comparable companies across both regions, including ON Holding, Crocs, Dr. Martens, Nike, and Adidas.
Investment risks
A price target should already reflect the opportunities and risks over the forecast horizon, but the point estimate needs a companion discussion of events that could hurt performance. Sources include the risk factors in the annual report, earnings call transcripts, investor presentations, and news releases. Risks may be company-specific (a product or client revenue shortfall, a delayed launch or recall, execution failures), industry-wide (cyclicality, disruptive entrants, regulatory pressure), or macroeconomic (large moves in inflation, interest rates, or currencies). The most important risks should be translated explicitly into the valuation, for example by running different jet fuel price scenarios for an airline or focusing on the timing and likelihood of drug approvals for a health care company.
Weight-loss drugs such as Ozempic are treated as a growth driver for some drug makers, but they also create risk for food companies. A 2023 Walmart study of its pharmacy and grocery data found that customers using GLP-1 drugs bought less food than those who did not, and other research shows lower consumption of ultraprocessed food and of food overall among GLP-1 users.
Sustainability and other factors
A thorough report often devotes a section to sustainability and related factors, with emphasis that varies by jurisdiction and industry. In places like the European Union, where a large share of institutional investors follow ESG principles, this section may cover a company’s strengths, vulnerabilities, and controversies. Where sustainability factors are financially material, for example for energy producers, heavy energy users such as electric utilities, or firms whose products depend on energy, a fuller analysis of energy transition plans is warranted. Toyota, for instance, describes a multipathway sustainability strategy aimed at carbon neutrality in its North American operations by 2035; alongside electrifying its lineup, it is pilot-testing a renewable gasoline blend with Chevron, reflecting the expectation that gasoline vehicles will stay on the road well into the 2030s.
This program lets university teams of three to five students study a publicly traded company chosen by their local CFA Society and deliver written and oral research. Winners are judged on the thoroughness of the analysis, not on whether the stock price prediction proves correct, and they advance to regional, national, and global rounds. As of 2025 the challenge had grown to well over 1,000 universities across almost 100 countries and regions, and across 18 years of competition the global champions came from 15 universities and 12 countries and regions.
The elements of a research report are broadly similar across firms, but the analyst’s perspective sets the two main report types apart. Sell-side analysts usually work at investment banks and produce reports for the firm’s clients. Buy-side analysts usually work inside asset managers and produce internal reports that support investment decisions. Both aim to inform better decisions, yet they differ in audience, purpose, and constraints.
| Feature | Sell-side research | Buy-side research |
|---|---|---|
| Primary audience | Outside clients: investors, traders, institutions, and retail buyers | The firm’s own investment teams and managers |
| Objective | Deliver research and recommendations to clients | Support the firm’s own investment decisions |
| Depth of analysis | Wide coverage of many names in a standardized format | Concentrated on names or sectors matching the strategy |
| Valuation | Standard models such as DCF and multiples, with an earnings-forecast focus | Sometimes proprietary models fitted to the firm being valued |
| Level of detail | Fairly general, for a wide readership | Tailored to in-house decisions |
| Regulatory constraints | Constrained by the firm’s ties to covered and banking clients | Mostly unconstrained, since output stays in-house |
Sell-side research
Investment banks fold equity research into a business model built around underwriting and issuing securities, corporate advisory work, and broker/dealer trading. Research teams focus on industry sectors and on selected companies within them, and sector analysts often bring deep, sometimes firsthand, industry knowledge. Regulation separates research from underwriting and trading to protect the objectivity of recommendations. That separation limits conflicts of interest: analysts cannot receive material non-public information, such as a pending merger or offering, unless it is made public, and they may not publish reports during a blackout window that brackets an IPO or a follow-on equity offering. The second European Markets in Financial Instruments Directive (MiFID II) pushed the separation further by requiring asset managers to pay for research separately from trade execution.
Because research is usually a cost center rather than a revenue source, sell-side firms are strategic about it. They must decide which industries to cover, how many companies to cover in each, and what kind of companies to follow. Trading commissions are one revenue link, so coverage tends to favor stocks with high expected trading volume, and strong research can attract sophisticated clients such as hedge funds. For large issuers, being covered by a major underwriter signals credibility, widens the information available to investors, and reduces information asymmetry. Sell-side analysts are nonetheless reluctant to publish sell ratings, which can sour trading sentiment and strain relationships with company management. Taking a contrarian, below-consensus view is public and reputationally risky, so it demands high conviction, though analysts do move between buy and hold and sometimes issue sell ratings, especially after a rapid price run-up.
Bloomberg’s Consensus Overview (EEO) function aggregates analyst estimates for a stock. For Tesla Inc. (TSLA) on 24 April 2025, the screen showed estimated adjusted (non-GAAP) EPS of USD0.494 for the quarter ending 30 June 2025, based on 34 analysts and down from prior estimates, while 26 analysts forecast GAAP EPS and 37 analysts contributed to the revenue estimate.
Buy recommendations on Tesla bottomed in March 2024, near what turned out to be the lowest prices of the period, as many analysts switched to hold. Buys then rebuilt through mid-2024, and the stock surged late in the year as ratings shifted further toward buy, even while price targets sat below the traded price. When both the broad US market and Tesla fell sharply in early 2025, analysts were slow to reverse course: about 54 percent still rated the stock buy as of late April 2025.
Buy-side research
Buy-side research is usually confidential and shared only with a firm’s decision makers, where investment committees use it to support new positions and monitor existing ones. A stock that gets a report has typically survived a screening process: start from a defined universe such as an index, apply quantitative criteria aligned with the strategy (for example a minimum earnings growth rate for a growth investor), add secondary criteria to confirm fit, and refine until few enough stocks remain that each can be researched in depth. Because buy-side firms answer only to their own strategy, they have more freedom than the sell side to pursue smaller stocks that receive little institutional attention.
Equity screening
Screening tools narrow a large universe down to a shortlist worth deep research. A simple screen might start from an index, then filter by sector, market capitalization, and a profitability threshold. On a Bloomberg equity screening (EQS) example, a starting universe of roughly 561,000 securities was cut to S&P 500 members, then to industrials, then to a market capitalization above USD50 billion, and finally to profit margins above 20 percent, leaving just three companies. The weakness of screening is that arbitrary thresholds can drop attractive candidates that just miss one cut-off, so analysts should treat a screen as a starting point rather than a verdict.
An analyst has 10 Consumer Staples stocks and wants the best two or three for deep research, filtering for a high return on capital (ROC), modest leverage, and a low equity beta.
| Stock | ROC | ROC rank | Debt-to-assets | Debt rank | Equity beta | Beta rank |
|---|---|---|---|---|---|---|
| 1 | 8% | 7 | 49% | 7 | 0.49 | 3 |
| 2 | 23% | 1 | 60% | 10 | 0.44 | 1 |
| 3 | 8% | 7 | 45% | 6 | 0.48 | 2 |
| 4 | 12% | 4 | 52% | 9 | 0.64 | 6 |
| 5 | 9% | 6 | 37% | 5 | 0.81 | 10 |
| 6 | 7% | 9 | 30% | 3 | 0.67 | 7 |
| 7 | 5% | 10 | 26% | 2 | 0.77 | 9 |
| 8 | 11% | 5 | 49% | 7 | 0.58 | 5 |
| 9 | 16% | 3 | 35% | 4 | 0.54 | 4 |
| 10 | 20% | 2 | 22% | 1 | 0.71 | 8 |
| Average | 11.9% | 40.5% | 0.613 |
Research by activist short sellers
Buy-side research supports buying, holding, and selling. Activist short sellers research stocks they expect to fall sharply, usually because of misinformation or fraud not yet reflected in the price. Unlike ordinary buy-side reports, which stay confidential, activist short sellers first release research to their limited partners and then circulate it publicly to influence the market consensus, move the price, and attract new clients. Hindenburg Research is a well-known example: it started in 2017 as the pen name Nathan Anderson used to publish short-selling ideas on the site Seeking Alpha, drew wide attention with its September 2020 report alleging fraud at the electric-vehicle start-up Nikola (whose founder was later criminally convicted of securities fraud after an SEC investigation), and closed in January 2025 with a team of only 11 staff after clearing its pipeline of cases.
Communicating the analysis
All equity research should meet the highest analytical and ethical standards. Good writing cannot rescue weak analysis, but weak writing can undermine excellent analysis. An effective report:
- delivers current, up-to-date information;
- uses plain, sharp language;
- stays objective and thoroughly researched, spelling out its main assumptions;
- keeps facts and opinions clearly apart;
- ties analysis, forecasts, valuation, and recommendation together so they agree;
- shows enough detail that a reader can challenge the valuation independently;
- names the main risks the investment carries; and
- discloses any conflicts of interest the analyst may have.
Market participants disagree about what securities are worth, and they express that disagreement through trading. Far from a flaw, this range of views drives price discovery and supports efficient markets, so contrarian opinions that run against consensus add value by testing the status quo. This section explains why analysts using the same modeling approach can still reach very different values for the same stock.
Hard-to-value equities
A stock is called hard to value when well-informed participants disagree widely about its intrinsic worth. At the end of August 2024, Nvidia, the dominant maker of chips for artificial intelligence and a stock that had risen almost eightfold over the prior two years, traded near USD120 per share. Across 32 analysts posting targets on 29 and 30 August 2024, more than half sat between USD130 and USD150, several reached USD170 or higher (one at USD200), and a few fell below the recent price, with one as low as USD90. One target was thus more than 50 percent below another for the same stock on the same days. Three distinctions usually explain such gaps: differing views on revenue growth, differing views on profitability, and differing terminal value estimates.
The growth rate implied by the current price
A useful check sets the current price equal to intrinsic value in a present value model and then solves for one hidden assumption. Using a two-stage model for free cash flow to equity (FCFE):
Each analyst forecasts the FCFE over a horizon of n years and for the year beyond it, the horizon length n, the cost of equity r-sub-e, and the long-run FCFE growth rate g-sub-l for years after the horizon. If the growth rate is the only unknown, the model rearranges to solve for it:
The intuition is that the growth rate baked into today’s market value equals the cost of equity less the one-year-ahead FCFE yield measured at the horizon’s end. The bracketed denominator is the terminal value that intrinsic value would require in order to match the current price.
Merlion Microtech, a Singapore-listed GPU chip maker, has an equity market capitalization of SGD30,000 million. Two analysts share the same near-term FCFE forecast but differ in horizon length; both use a 12 percent cost of equity. Analyst A stops at Year 3 (with Year 4 FCFE as the first post-horizon cash flow); Analyst B extends two years further.
| Year | Analyst A FCFE | Analyst B FCFE | Analyst A PV | Analyst B PV |
|---|---|---|---|---|
| 1 | 500 | 500 | 446.4286 | 446.4286 |
| 2 | 750 | 750 | 597.8954 | 597.8954 |
| 3 | 1,500 | 1,500 | 1,067.6704 | 1,067.6704 |
| 4 | 2,000 | 2,000 | — | 1,271.0362 |
| 5 | — | 2,500 | — | 1,418.5671 |
| 6 | — | 3,000 | — | — |
| Sum of PVs | 2,111.9944 | 4,801.5976 |
The same figures can lead to opposite conclusions. Analyst A might judge the 6.9 percent implied growth too optimistic and avoid the stock, while Analyst B might see modest implied growth as reasonable or even low and treat it as a reason to buy.
Free cash flow valuation drivers
Intrinsic value is driven by expected future free cash flow, or can be written as a multiple of a fundamental such as earnings. Three FCFE relationships underpin the analysis:
Every free cash flow forecast embeds views on revenue, profitability, investment needs, and sometimes financing, plus a long-run growth assumption.
Revenue and profitability
Strong revenue growth is often read as value creation, because participants extrapolate it into higher free cash flow. Analysts should be careful, though, since revenue changes can move other drivers, above all profit margins. The following matrix summarizes the likely direction of the equity value change.
| Net margin up | Net margin down | No margin change | |
|---|---|---|---|
| Revenue up | Value change larger than the revenue change | Value change smaller than revenue change; may be negative | Value change equal to revenue change |
| Revenue down | Value change larger than the revenue fall; may be positive | Negative value change larger than the revenue fall | Value change equal to the revenue fall |
| No revenue change | Positive value change from better margin | Negative value change from weaker margin | No value change |
Positive revenue surprises usually lift value, but if they arrive with cost pressure that squeezes margins, the net effect can turn negative.
Analyst A values Merlion Microtech at SGD25,838 million using a base case with a 12 percent cost of equity and a 6 percent long-run growth rate, a 10 percent net margin, and the original FCFE path. The analyst then assumes revenue rises 10 percent per year for four years, but supply chain issues cut the net margin by 25 basis points each year (from 10 percent to 9 percent by Year 4), with net investment and net debt issued unchanged.
| Year | Revenue | Net margin | Net income | FCFE |
|---|---|---|---|---|
| 1 | 8,800 | 9.75% | 858 | 558 |
| 2 | 13,200 | 9.50% | 1,254 | 804 |
| 3 | 26,400 | 9.25% | 2,442 | 1,542 |
| 4 | 35,200 | 9.00% | 3,168 | 1,968 |
Investment
Investment expenditures are meant to add value, so the net investment inside FCFE can foreshadow future revenue, profit, and cash flow gains. A good narrative connects revenue, expenses, and investment rather than treating them separately.
Concerned that assuming revenue growth without extra investment overstates value, Analyst A raises both revenue and net investment by 10 percent versus the base case, returns the net margin to 10 percent, and leaves net debt issued unchanged, keeping the 12 percent cost of equity and 6 percent long-run growth.
| Year | Original FCFE | Revised FCFE | Change |
|---|---|---|---|
| 1 | 500 | 330 | −34% |
| 2 | 750 | 650 | −13.3% |
| 3 | 1,500 | 1,550 | 3.3% |
| 4 | 2,000 | 2,160 | 8% |
The link between investment and long-run growth runs through return on capital, as summarized below.
| Investment assumption | Free cash flow outcome | Long-run growth implication |
|---|---|---|
| Investment growth above income growth | Free cash flow falls | Higher reinvestment rate; lower return on capital |
| Investment growth equal to income growth | No pressure on free cash flow | Consistent with stable long-run growth |
| Investment growth below income growth | Free cash flow rises | Lower reinvestment; higher return on capital |
Financing assumptions enter valuation too, but value creation comes mainly from a company’s operating strategy and results, not from the form of financing. Analysts should avoid building models that inadvertently manufacture value out of financing choices.
Divergence of opinion
A common misconception is that reports built on similar historical data should converge on a consensus price. In reality, differing views of the future widen the range of expectations, which aids price discovery. The InterGlobe Aviation case shows how far two analysts can part using the same firm’s data: a bearish report in mid-2024 expected a decline of more than 40 percent, while a bullish report in early 2025 set a target well over twice the bearish one. For fiscal year 2026, the bearish analyst’s revenue forecast was 0.854 of the bullish analyst’s, and the bearish EBITDA forecast was only 0.651 of the bullish figure, so pessimism about near-term revenue and profit generation drove much of the gap. Perspective matters as well: a global analyst may view IndiGo’s parent as a way to gain Indian market exposure, while a locally based analyst may weigh region-specific competitive issues more heavily. Analysts will always disagree to some degree, and the size of the disagreement usually reflects differences in assumed growth, profitability, or both.